ArticleScience translational medicine2020
Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes.
Geetanjali Sharma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
64 papers cite itlatest 60 shown
this papertrialcites it